Idarubicin, melphalan and cyclophosphamide: An intensified high-dose regimen for the treatment of myeloma patients

Leukemia

Volumn 11, Issue SUPPL. 5, 1997, Pages

  Heyll, A ^a   Sohngen, D ^a   Kobbe, G ^a   Schneider, P ^a   Bauser, U ^a   Thiele, K P ^a   Wehmeier, A ^a   Sudhoff, T ^a   Quenzel, E M ^a   Rieth, C ^a   Wernet, P ^a   Fischer, J ^a   Frick, M ^a   Aul, C ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Autologous peripheral blood stem cell transplantation; Cyclophosphamide; High dose chemotherapy; Idarubicin; Melphalan; Multiple myeloma

Indexed keywords

CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; IDARUBICIN; MELPHALAN; MESNA; PREDNISONE; VINCRISTINE;

ADULT; CANCER REGRESSION; CARDIOTOXICITY; CLINICAL TRIAL; CONFERENCE PAPER; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTIPLE MYELOMA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PYREXIA IDIOPATHICA; SUBCUTANEOUS DRUG ADMINISTRATION; SUPRAVENTRICULAR TACHYCARDIA;

EID: 0031456102     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (6)